top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
New Therapies of Liver Diseases
New Therapies of Liver Diseases
Autore Toniutto Pierluigi
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 online resource (236 p.)
Soggetto topico Public health and preventive medicine
Soggetto non controllato acute-on-chronic liver failure
acute-on-chronic liver failure (ACLF)
alcoholic hepatitis
alpha-fetoprotein
ammonia
anti-mineralocorticoids
antivirals
ascites
autoantibodies
bleeding
cholangiocarcinoma
cirrhosis
cirrhotic ascites
clinical trials
colorectal cancer metastases
decompensated cirrhosis
decompensation
effective hypovolemia
Farnesoid X Receptor (FXR) agonist
functional cure
furosemide
HBV
HDV
hepatocellular carcinoma
human albumin
humoral response
immunosuppressant
immunotherapy
infection
liver cancer
liver injury
liver transplantation
liver transplantation (LT)
loop diuretics
Milan criteria
n/a
non-selective beta-blockers
Pan-Peroxisome Proliferator-Activated Receptor (PPAR) agonists
pharmacology
portal hypertension
portal-systemic shunt
primary biliary cholangitis
primary biliary cholangitis (PBC)
primary sclerosing cholangitis (PSC)
real-world
rifaximin
SARS-CoV-2
second line therapy
solid organ transplantation
statins
survival
survival rate
systemic treatment
targeted therapy
TIPS
tolvaptan
treatment response
unresectable hepatocellular carcinoma
ursodeoxycholic acid
ursodeoxycholic acid (UDCA)
vaccination
vaptans
varices
vigilance
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910566457403321
Toniutto Pierluigi  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Targeting the Microbiome for Disease Diagnosis and Therapy : New Frontiers for Personalized Medicine
Targeting the Microbiome for Disease Diagnosis and Therapy : New Frontiers for Personalized Medicine
Autore Laterza Lucrezia
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (280 p.)
Soggetto topico Medicine
Soggetto non controllato Graves-Basedow's diseases
Hashimoto's thyroiditis
autoimmunity
gut microbiota
irritable bowel syndrome
microbiota
microbiome
food components
nutrients
hematopoietic stem cell transplantation
fecal microbiota transplantation
aGvHD
antibiotic-resistant bacteria
cystic fibrosis
rabbits
intestinal dysbiosis
feces microbiome
beta-blocker
hemodialysis
next-generation sequencing
propensity score matching methods
violin plots
random sampling
analytical reproducibility
fecal matter transplantation
data disease subtypes
personalized medicine
maltodextrin
dip test
gallstone disease
16S rDNA gene diversity
blood biochemical characteristics
mesothelioma
16S RNA sequencing
species
probiotics and gut disease
probiotics and acute diverticulitis
probiotics and diverticular disease
probiotics mechanism of action
IgA Nephropathy
rifaximin
α1KI-CD89Tg mice
children
intermittent hypoxemia
obstructive sleep apnea
tonsil
weight status
oral microbiota
rheumatology diseases
biomarkers
artificial intelligence
machine learning
rheumatoid arthritis
Sjogren's syndrome
systemic lupus erythematosus
endometrial cancer
endometrial microbiome
gut microbiome
dysbiosis
estrogen metabolism
estrobolome
inflammation
antitumour treatment
prebiotics
probiotics
schizophrenia
depression
anxiety
functional genes
thymoma
genera
driver mutation
cardiovascular diseases
critically ill
intestinal permeability
recurrent cystitis
ISBN 3-0365-5611-7
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Targeting the Microbiome for Disease Diagnosis and Therapy
Record Nr. UNINA-9910637781403321
Laterza Lucrezia  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui